Atlantic Private Wealth »

Crispr Therapeutics shares owned by Atlantic Private Wealth

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Atlantic Private Wealth from 13F filings

Historical chart of Atlantic Private Wealth investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Atlantic Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Atlantic Private Wealth

Quarter filed Position value Share count Share price at filing
2024-09-30 $703 15 46.93
2024-06-30 $810 15 54.00
2024-03-31 $1.0k 15 68.13

More positions owned by Atlantic Private Wealth

Spdr S&p500 Etf Etf (SPY)
Vanguard Idx Fund Etf (VTI)
Vanguard Total Etf (VXUS)
iShares iBonds Dec 2026 Term Treasury ETF Etf (IBTF)
Vanguard Extended Etf (VXF)
Vanguard World Etf (ESGV)
Select Sector SPDR Etf (XLE)
iShares TR Esg Awr Etf (EAGG)
iShares iBonds Dec 2024 Term Treasury ETF Etf (IBTE)
iShares TR Esg SCRND Etf (XVV)
iShares Trust Esg Etf (DMXF)
iShares iBonds Dec 2032 Term Treasury ETF Etf (IBTM)
iShares iBonds Dec 2030 Term Treasury ETF Etf (IBTK)
iShares iBonds Dec 2029 Term Treasury ETF Etf (IBTJ)
iShares S&P 500 Etf (IVV)

View all positions for Atlantic Private Wealth

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
BlackRock
T. Rowe Price Investment Management
State Street Corporation
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics